Nikolai Naryshkin, Ribonaut Therapeutics
In this week’s Tech Tuesday, UF Innovate is in Jupiter for our spring GatorPitch event. We are spotlighting Nikolai Naryshkin, CFO of Ribonaut Therapeutics, who won the Panelists’ Choice award at the biotech-focused event. Ribonaut Therapeutics, a UF-affiliated startup, develops new drugs to treat neurological diseases and movement disorders.
“How can we develop medicine for incurable diseases? Let’s learn more. Nikolai, tell us a little bit more about who you are and what you do,” said Julia Estroff, host of UF Innovate.
“I’m a scientist by training, and I operate a small biotech company located in Florida and in Boston, Massachusetts. Initially, we are focusing on individuals affected by neurological conditions such as Huntington’s disease, various ataxias, and myotonic dystrophy,” said Dr. Nikolai Naryshkin, CFO of Ribonaut Therapeutics.
Read more about UF-Affiliated Startup Wins the Panelists’ Choice Award at GatorPitch.
